Mindfulness Stress Management for Female Cancer Survivors Facing the Uncertainty of Disease Progression: A Randomized Controlled Study
Abstract
:1. Introduction
2. Methods
2.1. Study Design and Participants
2.2. Intervention Programs
2.3. Measurements
2.4. Data Analyses
2.5. Ethics Approval
3. Results
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- Daniel, S.; Venkateswaran, C.; Singh, C.; Hutchinson, A.; Johnson, M.J. “So, when a woman becomes ill, the total structure of the family is affected, they can’t do anything…” Voices from the community on women with breast cancer in India: A qualitative focus group study. Support. Care Cancer 2022, 30, 951–963. [Google Scholar] [CrossRef] [PubMed]
- Speca, M.; Carlson, L.E.; Goodey, E.; Angen, M. A Randomized, Wait-List Controlled Clinical Trial: The Effect of a Mindfulness Meditation-Based Stress Reduction Program on Mood and Symptoms of Stress in Cancer Outpatients. Psychosom. Med. 2000, 62, 613–622. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Palesh, O.; Scheiber, C.; Kesler, S.; Mustian, K.; Koopman, C.; Schapira, L. Management of side effects during and post-treatment in breast cancer survivors. Breast J. 2018, 24, 167–175. [Google Scholar] [CrossRef] [PubMed]
- Westin, S.N.; Sun, C.C.; Tung, C.S.; Lacour, R.A.; Meyer, L.A.; Urbauer, D.L.; Frumovitz, M.M.; Lu, K.H.; Bodurka, D. Survivors of gynecologic malignancies: Impact of treatment on health and well-being. J. Cancer Surviv. 2016, 10, 261–270. [Google Scholar] [CrossRef] [Green Version]
- Andersen, M.R.; Bowen, D.J.; Morea, J.; Stein, K.; Baker, F. Frequent Search for Sense by Long-Term Breast Cancer Survivors Associated with Reduced HRQOL. Women Health 2008, 47, 19–37. [Google Scholar] [CrossRef]
- Butow, P.N.; Turner, J.; Gilchrist, J.; Sharpe, L.; Smith, A.B.; Fardell, J.E.; Tesson, S.; O’Connell, R.; Girgis, A.; Gebski, V.; et al. Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence. J. Clin. Oncol. 2017, 35, 4066–4077. [Google Scholar] [CrossRef]
- Carlson, L.E.; Ursuliak, Z.; Goodey, E.; Angen, M.; Speca, M. The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up. Support. Care Cancer 2001, 9, 112–123. [Google Scholar] [CrossRef]
- Crosswell, A.D.; Moreno, P.; Raposa, E.B.; Motivala, S.J.; Stanton, A.L.; Ganz, P.A.; Bower, J.E. Effects of mindfulness training on emotional and physiologic recovery from induced negative affect. Psychoneuroendocrinology 2017, 86, 78–86. [Google Scholar] [CrossRef]
- Cheli, S.; Caligiani, L.; Martella, F.; De Bartolo, P.; Mancini, F.; Fioretto, L. Mindfulness and metacognition in facing with fear of recurrence: A proof-of-concept study with breast-cancer women. Psycho-Oncology 2019, 28, 600–606. [Google Scholar] [CrossRef]
- Park, H.; Oh, S.; Noh, Y.; Kim, J.Y.; Kim, J.-H. Heart Rate Variability as a Marker of Distress and Recovery: The Effect of Brief Supportive Expressive Group Therapy With Mindfulness in Cancer Patients. Integr. Cancer Ther. 2018, 17, 825–831. [Google Scholar] [CrossRef] [Green Version]
- Wu, G.; Feder, A.; Cohen, H.; Kim, J.J.; Calderon, S.; Charney, D.S.; Mathé, A.A. Understanding resilience. Front. Behav. Neurosci. 2013, 7, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rush, S.E.; Sharma, M. Mindfulness-Based Stress Reduction as a Stress Management Intervention for Cancer Care: A systematic review. J. Evid.-Based Integr. Med. 2017, 22, 348–360. [Google Scholar] [CrossRef] [PubMed]
- Byun, M.; Kim, E.; Kim, J. Physical and Mental Health Factors Associated with Poor Nutrition in Elderly Cancer Survivors: Insights from a Nationwide Survey. Int. J. Environ. Res. Public Health 2021, 18, 9313. [Google Scholar] [CrossRef] [PubMed]
- Borgi, M.; Collacchi, B.; Ortona, E.; Cirulli, F. Stress and coping in women with breast cancer: Unravelling the mechanisms to improve resilience. Neurosci. Biobehav. Rev. 2020, 119, 406–421. [Google Scholar] [CrossRef]
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef]
- Lee, Y.-H.; Lai, G.-M.; Lee, D.-C.; Lai, L.-J.T.; Chang, Y.-P. Promoting Physical and Psychological Rehabilitation Activities and Evaluating Potential Links Among Cancer-Related Fatigue, Fear of Recurrence, Quality of Life, and Physiological Indicators in Cancer Survivors. Integr. Cancer Ther. 2018, 17, 1183–1194. [Google Scholar] [CrossRef] [Green Version]
- Simard, S.; Savard, J. Fear of Cancer Recurrence Inventory: Development and initial validation of a multidimensional measure of fear of cancer recurrence. Support. Care Cancer 2009, 17, 241–251. [Google Scholar] [CrossRef]
- Cella, D.F.; Tulsky, D.S.; Gray, G.; Sarafian, B.; Linn, E.; Bonomi, A.; Silberman, M.; Yellen, S.B.; Winicour, P.; Brannon, J. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J. Clin. Oncol. 1993, 11, 570–579. [Google Scholar] [CrossRef]
- Cheung, Y.B.; Goh, C.; Wee, J.; Khoo, K.S.; Thumboo, J. Measurement properties of the Chinese language version of the functional assessment of cancer therapy-general in a Singaporean population. Ann. Acad. Med. Singap. 2009, 38, 225–259. [Google Scholar]
- Deimling, G.T.; Brown, S.P.; Albitz, C.; Burant, C.J.; Mallick, N. The relative importance of cancer-related and general health worries and distress among older adult, long-term cancer survivors. Psycho-Oncology 2017, 26, 182–190. [Google Scholar] [CrossRef]
- Wu, H.S.; Harden, J.K. Symptom burden and quality of life in survivorship: A review of the literature. Cancer Nurs. 2015, 38, E29–E54. [Google Scholar] [CrossRef] [PubMed]
- Amiel, C.R.; Fisher, H.M.; Carver, C.S.; Antoni, M.H. The importance of stress management among postresection breast cancer patients. Future Oncol. 2016, 12, 2771–2774. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Crist, J.V.; Grunfeld, E.A. Factors reported to influence fear of recurrence in cancer patients: A systematic review. Psycho-Oncology 2013, 22, 978–986. [Google Scholar] [CrossRef] [PubMed]
- Sullivan, E.S.; Rice, N.; Kingston, E.; Kelly, A.; Reynolds, J.V.; Feighan, J.; Power, D.G.; Ryan, A.M. A national survey of oncology survivors examining nutrition attitudes, problems and behaviours, and access to dietetic care throughout the cancer journey. Clin. Nutr. ESPEN 2021, 41, 331–339. [Google Scholar] [CrossRef] [PubMed]
- Karim, S.; Benn, R.; Carlson, L.; Fouladbakhsh, J.; Greenlee, H.; Harris, R.; Henry, N.; Jolly, S.; Mayhew, S.; Spratke, L.; et al. Integrative Oncology Education: An Emerging Competency for Oncology Providers. Curr. Oncol. 2021, 28, 853–862. [Google Scholar] [CrossRef] [PubMed]
Variable | Frequency Distribution (%) | Chi-Squared Test for Homogeneity | ||||||
---|---|---|---|---|---|---|---|---|
MSM (n = 29) | Control (n = 25) | Total (n = 54) | ||||||
n | % | n | % | n | % | χ2-Value | p-Value | |
Age (y/o) | ||||||||
30–39 | 1 | 3.4 | 2 | 8.0 | 3 | 5.6 | 3.505 | 0.320 |
40–49 | 7 | 24.1 | 7 | 28.0 | 14 | 25.9 | ||
50–59 | 10 | 34.5 | 12 | 48.0 | 22 | 40.7 | ||
≥60 | 11 | 37.9 | 4 | 16.0 | 15 | 27.8 | ||
Marital status | ||||||||
Single | 4 | 13.8 | 5 | 20.0 | 9 | 16.7 | 1.107 | 0.893 |
Married | 17 | 58.6 | 12 | 48.0 | 29 | 5.37 | ||
Separation | 2 | 6.9 | 2 | 8.0 | 4 | 7.4 | ||
Divorced | 4 | 13.8 | 5 | 20.0 | 9 | 16.7 | ||
Widowed | 2 | 6.9 | 1 | 4.0 | 3 | 5.6 | ||
Education | ||||||||
Below high school | 0 | 0.0 | 6 | 24.0 | 6 | 11.1 | ||
High school | 11 | 37.9 | 10 | 40.0 | 21 | 38.9 | ||
College and higher | 18 | 62.1 | 9 | 360 | 27 | 50.0 | ||
Cancer type | ||||||||
Uterine cancer | 3 | 10.3 | 2 | 8.0 | 5 | 9.2 | 0.460 | 0.928 |
Ovarian cancer | 2 | 6.7 | 1 | 4.0 | 3 | 5.6 | ||
Breast cancer | 24 | 82.8 | 22 | 88.0 | 46 | 85.2 | ||
Cancer stage | ||||||||
I | 12 | 41.4 | 8 | 32.0 | 20 | 37.0 | 3.064 | 0.382 |
II | 9 | 31.0 | 12 | 48.0 | 21 | 38.9 | ||
III | 8 | 27.6 | 5 | 20.0 | 13 | 24.1 | ||
Survival period | ||||||||
Within 5 years | 9 | 31.0 | 9 | 36.0 | 18 | 33.3 | 3.477 | 0.176 |
5–10 years | 12 | 41.4 | 14 | 56.0 | 26 | 48.1 | ||
>10 years | 8 | 27.6 | 2 | 8.0 | 10 | 18.5 | ||
Sense of anxiety | ||||||||
No | 21 | 72.4 | 15 | 60.0 | 36 | 66.7 | 0.931 | 0.335 |
Yes | 8 | 37.6 | 10 | 40.0 | 18 | 33.3 | ||
Sense of depression | ||||||||
No | 23 | 79.3 | 16 | 64.0 | 39 | 72.2 | 1.569 | 0.210 |
Yes | 6 | 20.7 | 9 | 36.0 | 15 | 27.8 | ||
Level of FOR Scale | ||||||||
None | 0 | 0.0 | 1 | 4.0 | 1 | 1.9 | 1.914 | 0.590 |
Mild | 16 | 55.2 | 16 | 64.0 | 32 | 59.3 | ||
Moderate | 10 | 34.5 | 6 | 24.0 | 16 | 29.6 | ||
Severe | 3 | 10.3 | 2 | 8.0 | 5 | 9.3 |
Variables | MSM Group (n = 29) | Control Group (n = 25) | ||||||
---|---|---|---|---|---|---|---|---|
Mean | SD | t Value | p Value | Mean | SD | t Value | p Value | |
FOR | ||||||||
T0 | 2.560 | 0.861 | 2.237 | 0.698 | ||||
T1 | 2.200 | 0.855 | 2.554 | 0.768 | ||||
T2 | 2.303 | 0.773 | 2.368 | 0.806 | ||||
T1–T0 | −0.361 | 0.575 | −3.380 ** | 0.002 | 0.317 | 0.747 | 2.122 * | 0.044 |
T2–T0 | −0.257 | 0.666 | −2.081 * | 0.047 | 0.130 | 0.705 | 0.927 | 0.363 |
QOL | ||||||||
T0 | 3.546 | 0.610 | 3.621 | 0.832 | ||||
T1 | 4.046 | 0.588 | 3.992 | 0.554 | ||||
T2 | 4.049 | 0.598 | 3.998 | 0.600 | ||||
T1–T0 | 0.500 | 0.643 | 4.186 *** | 0.000 | 0.371 | 0.595 | 3.116 ** | 0.005 |
T2–T0 | 0.478 | 0.642 | 3.934 ** | 0.001 | 0.377 | 0.612 | 3.079 ** | 0.005 |
Outcome Variables | The Assumption of Homogeneity of Regression Slopes | Levene’s Test of Equality of Error Variances | Tests of Between-Group Effects | Adjusted Posttest Means | |||||
---|---|---|---|---|---|---|---|---|---|
F Value | p Value § | F Value | p Value § | F Value | p Value | MSM | Control | ||
FOR | T1 | 1.113 | 0.296 | 1.995 | 0.164 | 11.209 | 0.002 ** | 2.097 † | 2.674 † |
T2 | 0.053 | 0.819 | 0.619 | 0.435 | 2.357 | 0.131 | 2.210 † | 2.476 † | |
QOL | T1 | 0.089 | 0.767 | 3.112 | 0.084 | 0.446 | 0.507 | 4.062 ‡ | 3.974 ‡ |
T2 | 0.101 | 0.752 | 2.576 | 0.115 | 0.290 | 0.593 | 4.060 ‡ | 3.986 ‡ |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lee, J.-T.; Lee, Y.-H.; Chang, Y.-P. Mindfulness Stress Management for Female Cancer Survivors Facing the Uncertainty of Disease Progression: A Randomized Controlled Study. Int. J. Environ. Res. Public Health 2022, 19, 4497. https://doi.org/10.3390/ijerph19084497
Lee J-T, Lee Y-H, Chang Y-P. Mindfulness Stress Management for Female Cancer Survivors Facing the Uncertainty of Disease Progression: A Randomized Controlled Study. International Journal of Environmental Research and Public Health. 2022; 19(8):4497. https://doi.org/10.3390/ijerph19084497
Chicago/Turabian StyleLee, Jih-Teng, Yi-Hua Lee, and Yuan-Ping Chang. 2022. "Mindfulness Stress Management for Female Cancer Survivors Facing the Uncertainty of Disease Progression: A Randomized Controlled Study" International Journal of Environmental Research and Public Health 19, no. 8: 4497. https://doi.org/10.3390/ijerph19084497
APA StyleLee, J. -T., Lee, Y. -H., & Chang, Y. -P. (2022). Mindfulness Stress Management for Female Cancer Survivors Facing the Uncertainty of Disease Progression: A Randomized Controlled Study. International Journal of Environmental Research and Public Health, 19(8), 4497. https://doi.org/10.3390/ijerph19084497